We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+17.1%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$72.5B
AUM Growth
+$8.64B
Cap. Flow
-$411M
Cap. Flow %
-0.57%
Top 10 Hldgs %
21.89%
Holding
3,099
New
114
Increased
2,324
Reduced
599
Closed
47

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$108M
2
MSFT icon
Microsoft
MSFT
+$73.2M
3
AMZN icon
Amazon
AMZN
+$49.5M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$27.8M
5
META icon
Meta Platforms (Facebook)
META
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.78%
2 Financials 13.46%
3 Healthcare 13.26%
4 Consumer Discretionary 12.31%
5 Communication Services 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RFL icon
2576
Rafael Holdings
RFL
$107M
$364K ﹤0.01%
15,828
+1,961
+14% +$38.6K
LONA
2577
LeonaBio Inc
LONA
$72.1M
$363K ﹤0.01%
+1,060
New +$250K
MAX icon
2578
MediaAlpha
MAX
$821M
$363K ﹤0.01%
+9,302
New +$361K
NSSC icon
2579
Napco Security Technologies
NSSC
$1.48B
$363K ﹤0.01%
27,666
+1,650
+6% +$22.2K
ASO icon
2580
Academy Sports + Outdoors
ASO
$2.98B
$362K ﹤0.01%
+17,443
New +$283K
IMXI icon
2581
International Money Express
IMXI
$367M
$362K ﹤0.01%
23,317
+5,463
+31% +$84.6K
CALA
2582
DELISTED
Calithera Biosciences, Inc
CALA
$362K ﹤0.01%
3,688
+276
+8% +$24.2K
EGAN icon
2583
eGain
EGAN
$201M
$361K ﹤0.01%
30,577
+3,349
+12% +$47.4K
KALV
2584
DELISTED
KalVista Pharmaceuticals
KALV
$361K ﹤0.01%
18,989
+3,236
+21% +$55.5K
CECO icon
2585
Ceco Environmental
CECO
$4.14B
$359K ﹤0.01%
51,562
+6,415
+14% +$47.1K
XBIT icon
2586
XBiotech
XBIT
$69.2M
$359K ﹤0.01%
22,909
+3,131
+16% +$57.7K
CTSO icon
2587
Cytosorbents Corp
CTSO
$22.6M
$358K ﹤0.01%
44,923
+4,752
+12% +$39.8K
ATLO icon
2588
AMES National
ATLO
$277M
$357K ﹤0.01%
14,849
+1,853
+14% +$39.3K
CARE icon
2589
Carter Bankshares
CARE
$731M
$357K ﹤0.01%
33,324
+4,768
+17% +$40.5K
ITOS
2590
DELISTED
iTeos Therapeutics
ITOS
$356K ﹤0.01%
10,527
+1,875
+22% +$49.6K
TXMD icon
2591
TherapeuticsMD
TXMD
$24M
$356K ﹤0.01%
5,882
-794
-12% -$54.2K
MVBF icon
2592
MVB Financial
MVBF
$389M
$355K ﹤0.01%
15,647
+2,049
+15% +$38.9K
GLRE icon
2593
Greenlight Captial
GLRE
$506M
$352K ﹤0.01%
48,140
+4,344
+10% +$32.1K
PRVL
2594
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$352K ﹤0.01%
15,258
+1,050
+7% +$13.3K
MUFG icon
2595
Mitsubishi UFJ Financial
MUFG
$254B
$351K ﹤0.01%
79,311
+20,540
+35% +$87.3K
NKSH icon
2596
National Bankshares
NKSH
$268M
$351K ﹤0.01%
11,206
+1,354
+14% +$40K
PRTK
2597
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$351K ﹤0.01%
56,067
+3,579
+7% +$21.1K
APLT
2598
DELISTED
Applied Therapeutics
APLT
$350K ﹤0.01%
15,902
+1,000
+7% +$20.8K
CNBKA
2599
DELISTED
Century Bancorp Inc/Mass
CNBKA
$350K ﹤0.01%
4,523
+538
+14% +$40.2K
PLPC icon
2600
Preformed Line Products
PLPC
$2.28B
$349K ﹤0.01%
5,097
+624
+14% +$36.1K

Similar funds

RhumbLine Advisers's Q4 2020 Portfolio in Review

As of Q4 2020, RhumbLine Advisers held 3,099 positions worth $72.5B, up 14% from $63.8B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

RhumbLine Advisers's Q4 2020 filing shows 114 new, 2,324 increased, 599 reduced and 47 closed positions. Its largest new stake was Apartment Income REIT Corp.: 482,605 shares worth $18.5M. The largest sale was Apple, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2020 buy was Apartment Income REIT Corp.: 482,605 shares worth $18.5M.
  • RhumbLine Advisers added most to Tesla in Q4 2020, an estimated $278M increase.
  • RhumbLine Advisers's biggest Q4 2020 reduction was Apple, cutting an estimated $108M.
  • RhumbLine Advisers fully exited Immunomedics Inc in Q4 2020, selling an estimated $20.4M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $72.5B portfolio in Q4 2020.
  • RhumbLine Advisers opened 114 new positions and closed 47 in Q4 2020.
  • RhumbLine Advisers's portfolio value rose 14% quarter-over-quarter to $72.5B.

Based on RhumbLine Advisers's 13F filing for Q4 2020, filed 10 Feb 2021.